Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Feb 29 04:00PM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)-1.52 Insider Own26.36% Shs Outstand52.56M Perf Week6.05%
Market Cap276.47M Forward P/E- EPS next Y-1.08 Insider Trans0.18% Shs Float38.71M Perf Month14.85%
Income-61.76M PEG- EPS next Q-0.32 Inst Own70.63% Short Float0.48% Perf Quarter54.71%
Sales1.42M P/S194.69 EPS this Y28.51% Inst Trans-0.21% Short Ratio0.76 Perf Half Y54.25%
Book/sh1.70 P/B3.09 EPS next Y17.71% ROA-51.46% Short Interest0.19M Perf Year121.01%
Cash/sh1.95 P/C2.70 EPS next 5Y-1.60% ROE-69.60% 52W Range1.86 - 5.79 Perf YTD0.38%
Dividend Est.- P/FCF- EPS past 5Y-40.24% ROI-69.29% 52W High-9.15% Beta0.21
Dividend TTM- Quick Ratio5.45 Sales past 5Y69.56% Gross Margin15.25% 52W Low182.80% ATR (14)0.32
Dividend Ex-Date- Current Ratio5.45 EPS Y/Y TTM45.42% Oper. Margin-4419.54% RSI (14)58.43 Volatility7.36% 5.90%
Employees58 Debt/Eq0.07 Sales Y/Y TTM-12.32% Profit Margin-4340.06% Recom1.00 Target Price12.20
Option/ShortYes / Yes LT Debt/Eq0.06 EPS Q/Q31.47% Payout- Rel Volume0.73 Prev Close5.48
Sales Surprise46.39% EPS Surprise14.93% Sales Q/Q51.53% EarningsNov 07 AMC Avg Volume244.48K Price5.26
SMA205.85% SMA505.08% SMA20038.41% Trades Volume177,551 Change-4.01%
Date Action Analyst Rating Change Price Target Change
Oct-06-23Resumed BTIG Research Buy $15
Aug-31-23Initiated H.C. Wainwright Buy $12
May-24-22Initiated Cantor Fitzgerald Overweight $15
May-26-20Initiated William Blair Outperform
May-26-20Initiated Jefferies Buy $24
May-26-20Initiated BTIG Research Buy $28
May-26-20Initiated BofA/Merrill Buy $21
Feb-26-24 03:58AM
Feb-21-24 08:50AM
Jan-17-24 08:50AM
Nov-07-23 04:01PM
07:00AM Loading…
Oct-16-23 07:00AM
Sep-13-23 01:22PM
Sep-12-23 07:00AM
Sep-06-23 08:00AM
Aug-29-23 07:00AM
Aug-08-23 05:50PM
Jul-13-23 07:30AM
Jun-02-23 04:01PM
07:29AM Loading…
Jun-01-23 07:29AM
May-26-23 07:57AM
May-14-23 08:19AM
May-12-23 08:15AM
May-09-23 04:01PM
Apr-29-23 08:19AM
Apr-25-23 07:59AM
Mar-29-23 04:06PM
Mar-20-23 01:11PM
Mar-01-23 05:21AM
Feb-28-23 05:17AM
Feb-27-23 07:59AM
Feb-07-23 01:23PM
Feb-06-23 07:56AM
06:42PM Loading…
Jan-17-23 06:42PM
Dec-20-22 08:52AM
Nov-09-22 08:00AM
Nov-08-22 05:45PM
Sep-21-22 06:11AM
Sep-13-22 04:01PM
Sep-10-22 08:00AM
Sep-08-22 07:00AM
Sep-06-22 07:00AM
Aug-31-22 02:08PM
Aug-29-22 07:00AM
Aug-11-22 08:05AM
Aug-09-22 08:25AM
Jul-27-22 09:40AM
Jul-13-22 09:21AM
Jul-05-22 07:00AM
Jun-17-22 04:01PM
May-26-22 07:00AM
May-25-22 01:07PM
May-10-22 08:35AM
May-05-22 07:00AM
Apr-29-22 09:07AM
Apr-27-22 06:31AM
Apr-25-22 07:00AM
Apr-21-22 07:00AM
Apr-13-22 07:00AM
Apr-08-22 07:34AM
Mar-09-22 07:00AM
Mar-07-22 07:00AM
Mar-02-22 04:28AM
Feb-28-22 07:00AM
Feb-17-22 07:00AM
Jan-24-22 12:37PM
Nov-11-21 07:00AM
Nov-09-21 04:05PM
Nov-02-21 07:00AM
Oct-04-21 07:00AM
Sep-29-21 02:58PM
Sep-21-21 07:00AM
Sep-20-21 07:00AM
Sep-13-21 07:00AM
Sep-09-21 04:05PM
Sep-07-21 07:00AM
Sep-03-21 10:24AM
Aug-17-21 07:35AM
Aug-09-21 04:05PM
Aug-03-21 09:01AM
Jul-26-21 04:05PM
Jul-12-21 07:00AM
Jun-30-21 07:00AM
Jun-23-21 03:23PM
Jun-09-21 05:48AM
Jun-08-21 04:30PM
Jun-02-21 07:00AM
Jun-01-21 07:00AM
May-24-21 07:00AM
May-11-21 04:05PM
May-06-21 04:05PM
May-03-21 06:08AM
Apr-27-21 08:39AM
Mar-29-21 04:05PM
Mar-09-21 04:05PM
Lyra Therapeutics, Inc. is a clinical-stage therapeutics company. It develops novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose and throat, or ENT, diseases. The firms proprietary XTreo deliver medicines. The company was founded by Carmichael S. Roberts, George M. Whitesides, and Robert S. Langer in November 2005 and is headquartered in Watertown, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Waksal HarlanExecutive ChairNov 10Buy2.9625,00074,095261,966Nov 13 05:29 PM
PERCEPTIVE ADVISORS LLCDirectorMay 31Buy2.493,610,8328,999,99911,469,117Jun 02 04:11 PM
NBVM GP, LLC10% OwnerMay 31Buy2.431,805,4164,387,1612,521,745Jun 02 04:15 PM
ANDERSON EDWARD TDirectorMay 31Buy2.431,805,4164,387,1612,521,745Jun 02 04:11 PM